12:30-14:30 Wednesday, 26 April, 2017
Lunch Session- Novo Nordisk-Hall J
A New Horizon in the Treatment of the Cardio Metabolic Patient
Faculty: Hila Knobler, Naim Shechade
Time | Topic | Speaker |
12:30-13:00 | Lunch first and main courses | |
13:00-13:30 | Beyond Glucose Control - Liraglutide treatment in diabetes leading to CV risk reduction (LEADER® trial) | Hila Knobler |
13:30-13:55 | Beyond the SCALE – Liraglutide 3 mg in the treatment of obesity (SCALE® trial) | Naim Shechade |
13:55-14:10 | Q&A | |